Nephros (NEPH) Gross Profit (2010 - 2026)

Nephros has reported Gross Profit for 17 years, with the latest figure at $4.0 million in Q2 2026.

• On a quarterly basis, Gross Profit rose 44.04% year-over-year to $4.0 million in Q2 2026; TTM through Jun 2026 was $12.7 million, a 20.07% increase from a year earlier, with the FY2025 full-year figure at $11.6 million, up 33.27% from the prior year.
• Gross Profit was $4.0 million for Q2 2026 at Nephros, up from $3.0 million in the prior quarter.
• The five-year high for Gross Profit was $4.0 million in Q2 2026, with the low at $762000.0 in Q3 2022.
• Average Gross Profit over 5 years is $2.2 million, with a median of $2.2 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Gross Profit plunged 43.97% in 2022, then surged 187.93% in 2023.
• Over 5 years, Gross Profit stood at $1.5 million in 2022, then jumped by 33.93% to $2.0 million in 2023, then rose by 22.46% to $2.5 million in 2024, then advanced by 11.56% to $2.8 million in 2025, then surged by 45.82% to $4.0 million in 2026.
• The last three Gross Profit figures came in at $4.0 million (Q2 2026), $3.0 million (Q1 2026), and $2.8 million (Q4 2025), per Business Quant data.